Clinical trial
An Exploratory Clinical Study on the Safety and Efficacy of RN1201 Injection in the Treatment of Antibody-Mediated Diseases
NCT07072247 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Soochow University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Clinical Study on the Safety and Efficacy of RN1201 Injection in the Treatment of Antibody-Mediated Diseases
- Lead sponsor
- The First Affiliated Hospital of Soochow University
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- July 7, 2025
- Completion date
- July 30, 2027
- Enrollment
- 9 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
refractory immune-mediated platelet transfusion refractoriness, relapsed or refractory immune thrombocytopenia